ホーム > 末原泰人/ SUEHARA, Yasuhito

末原泰人

SUEHARA, Yasuhito

医学医療系　血液内科 , 講師
Department of Hematology, Institute of Medicine

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

21. 高度な骨髄線維化を認め診断に苦慮したリンパ形質細胞性リンパ腫の1例宝田亜矢子; 百瀬春佳; 栗田尚樹; 坂本竜弘 (+9 著者) 千葉滋
臨床血液 63: 503 (2022)
22. A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling. Yoshiaki Abe; Mamiko Sakata-Yanagimoto; Manabu Fujisawa; Hiroaki Miyoshi (+18 著者) Shigeru Chiba
Nature cell biology 24: 565 (2022)
23. [Acute myeloid leukemia harboring NUP98::DDX10]. Naoki Kurita; Takayasu Kato; Toru Nanmoku; Yumiko Maruyama (+9 著者) Shigeru Chiba
[Rinsho ketsueki] The Japanese journal of clinical hematology 63: 1397 (2022)
24. Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model. Yen T M Nguyen; Manabu Fujisawa; Tran B Nguyen; Yasuhito Suehara (+8 著者) Mamiko Sakata-Yanagimoto
Cancer science 112: 4931 (2021)
25. Retrospective analyses of other iatrogenic immunodeficiency‐associated lymphoproliferative disorders in patients with rheumatic diseases Daisuke Kaji; Manabu Kusakabe; Mamiko Sakata‐Yanagimoto; Kenichi Makishima (+18 著者) Shigeru Chiba
British Journal of Haematology 195: 585 (2021)
26. Ph陰性急性リンパ性白血病における小児レジメンを用いた当院での治療成績(Real-world experience of Ph(-)ALL treated with a pediatric regimen: a single center study) 吉澤有紀; 加藤貴康; 槇島健一; 伊藤由布 (+11 著者) 千葉滋
日本血液学会学術集会 83回: OS3 (2021)
27. VAV1 mutations contribute to development of T-cell neoplasms in mice. Kota Fukumoto; Mamiko Sakata-Yanagimoto; Manabu Fujisawa; Tatsuhiro Sakamoto (+12 著者) Shigeru Chiba
Blood 136: 3018 (2020)
28. Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κ. Kentaro Narita; Hiroki Kobayashi; Tomo Suzuki; Daisuke Ichikawa (+5 著者) Kosei Matsue
Clinical lymphoma, myeloma & leukemia 20: e805-e808 (2020)
29. Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status. Raksha Shrestha; Mamiko Sakata-Yanagimoto; Koichiro Maie; Motohiko Oshima (+22 著者) Shigeru Chiba
Blood advances 4: 845 (2020)
30. Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis. yasuhito suehara
Cancer science 110: 3375 (2019)
31. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma. Keiichiro Hattori; Mamiko Sakata-Yanagimoto; Manabu Kusakabe; Toru Nanmoku (+13 著者) Shigeru Chiba
Cancer science 110: 401 (2019)
32. Liquid biopsy for the identification of intravascular large B-cell lymphoma. Yasuhito Suehara; Mamiko Sakata-Yanagimoto; Keiichiro Hattori; Toru Nanmoku (+18 著者) Shigeru Chiba
Haematologica 103: e241-e244 (2018)
33. Liquid biopsy for the identification of intravascular large B-cell lymphoma. Yasuhito Suehara; Mamiko Sakata-Yanagimoto; Keiichiro Hattori; Toru Nanmoku (+18 著者) Shigeru Chiba
Haematologica 103: e241-e244 (2018)
34. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma Sharna Tanzima Nuhat; Mamiko Sakata-Yanagimoto; Daisuke Komori; Keiichiro Hattori (+7 著者) Shigeru Chiba
Cancer Science 109: 1682 (2018)
35. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Keiichiro Hattori; Mamiko Sakata-Yanagimoto; Yasuhito Suehara; Yasuhisa Yokoyama (+8 著者) Shigeru Chiba
Cancer science 109: 225 (2018)
36. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Keiichiro Hattori; Mamiko Sakata-Yanagimoto; Yasuhito Suehara; Yasuhisa Yokoyama (+8 著者) Shigeru Chiba
Cancer science 109: 225 (2018)
37. 骨髄異形成症候群の臨床像と体細胞遺伝子変異との関連平沢伸広; 小川誠司; 長谷川雄一; 千葉滋 (+7 著者) 小原直
Rinsho Ketsueki 59: 80 (2018)
38. 初発時と全身再発時のPCNSLの遺伝子異常の比較による、common precursor cellの存在の確認服部圭一朗; 坂田麻実子[柳元]; 末原泰人; 横山泰久 (+4 著者) 千葉滋
日本癌学会総会記事 76回: J (2017)
39. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry Kosei Matsue; Yuya Matsue; Kaoru Kumata; Yoshiaki Usui (+4 著者) Masami Takeuchi
HEMATOLOGICAL ONCOLOGY 35: 323 (2017)
40. Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group J. Hillengass; L. A. Moulopoulos; S. Delorme; V. Koutoulidis (+17 著者) E. Terpos
BLOOD CANCER JOURNAL 7: (2017)

« 1 2 3 »

1. EBM血液疾患の治療坂田(柳元)麻実子, 槇島健一, 末原泰人. (担当:分担執筆, 範囲:Topics: リンパ腫病型とゲノム異常)
中外医学社 2022年10月 (ISBN: 9784498225404)
2. がんゲノム医療結果報告書の読み方と患者への伝え方 : エキスパートパネルの実際末原泰人; 服部圭一朗; 千葉滋 (担当:分担執筆, 範囲:第7章シーケンスデータの品質の指標と変異・CNVデータの読み方)
医学と看護社 2020年5月 (ISBN: 9784909888105)
3. プレシジョン・メディシン : ビッグデータの構築・分析から臨床応用・課題まで = Precision medicine 末原泰人; 日下部学; 坂田(柳元), 麻実子; 千葉, 滋 (担当:分担執筆, 範囲:分担執筆, 範囲:第2編第2章第5節血液がんの変異遺伝子を標的とした個別化治療への応用－血液がんにおけるPRECISION MEDICINE-)
エヌ・ティー・エス 2018年 (ISBN: 9784860435806)

講演・口頭発表情報はまだありません。

知財情報はまだありません。

150 total views

末原泰人

SUEHARA, Yasuhito

この研究者の他の情報源

キーワードが似ている研究者

この研究者の情報を共有